Short Half-life Hypnotics Preserve Physical Fitness and Altitude Tolerance During Military Mountainous Training
Overview
Affiliations
Objective: We study the effect of short half-life hypnotics (zaleplon or zolpidem against placebo) on altitude tolerance in 12 nonacclimated male soldiers (age, 22.1 +/- 0.8 years; height, 177.8 +/- 1.7 cm; weight, 69.8 +/- 1.7 kg).
Methods: Soldiers were trained to practice mountaineering at high altitude (2,533-4,810 meters) during 3 periods (one per medication tested) of 4 days (D1-D4). In each period the nights were spent in a hut (3,613 m). Administration of hypnotics or placebo was then implemented at 9:45 p.m. Nocturnal arterial oxygen saturation (SaO2) and heart rate variability (HRV) were monitored. At 5:00 a.m. and 9:00 p.m. physical fitness was assessed using acute mountain sickness (AMS) score. At 5:00 p.m., a posteffort stand test was carried out to evaluate the orthoparasympathetic imbalance with fatigue.
Results: Nocturnal SaO2 correlated negatively with morning AMS scores (R = -0.820, p < 0.02) and HRV analysis favored the sympathetic modulation. Posteffort stand tests revealed that sympathetic modulation attenuated from D2 to D3 in treated groups.
Conclusion: The present study provides evidence that zolpidem or zaleplon improves sleep and subsequent physical fitness at altitude.
Wei C, Chen P, Lin S, Huang T, Sun L, Tseng C BMC Bioinformatics. 2022; 22(Suppl 5):628.
PMID: 35641924 PMC: 9153088. DOI: 10.1186/s12859-022-04749-0.
Corrigan S, Roberts S, Warmington S, Drain J, Main L BMC Public Health. 2021; 21(1):1701.
PMID: 34537038 PMC: 8449887. DOI: 10.1186/s12889-021-11595-x.
A hypothesis study on a four-period prevention model for high altitude disease.
Liu X, Yang X, Liu L, Qin X, Gao Y Mil Med Res. 2018; 5(1):2.
PMID: 29502526 PMC: 5781318. DOI: 10.1186/s40779-018-0150-0.
Taylor L, Chrismas B, Dascombe B, Chamari K, Fowler P Front Physiol. 2016; 7:83.
PMID: 27014084 PMC: 4779957. DOI: 10.3389/fphys.2016.00083.
Chen L, Zhao A, Zhang Q, Wu F, Ge Z, Ge H Mil Med Res. 2016; 3:5.
PMID: 26937286 PMC: 4774104. DOI: 10.1186/s40779-016-0075-4.